Integra LifeSciences Holdings Corp - Company Profile
Powered by 
All the sales intelligence you need on Integra LifeSciences Holdings Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Integra LifeSciences Holdings Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Integra LifeSciences Holdings Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Integra LifeSciences Holdings Corp (Integra) is a medical technology company that develops and manufactures engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, orthobiologic products, dermal regeneration products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for the measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. Integra is headquartered in Princeton, New Jersey, the US.
Headquarters
United States of America
Address
1100 Campus Road, Princeton, New Jersey, 08540
Website
www.integralife.com
Telephone
1 302 6365400
No of Employees
4,427
Industry
Medical Equipment
Ticker Symbol & Exchange
IART (NASD)
Revenue (2024)
$1.6B
1.5%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-7337.7%
(2024 vs 2023)
Market Cap*
$1.4B
Net Profit Margin (2024)
XYZ
-7,244.2%
(2024 vs 2023)
* As of and is in US$
Integra LifeSciences Holdings Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Neurosurgery | AccuDrain |
| Tissue Ablation | AmnioExcel |
| Dural Repair | Aquasonic |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Regulatory Approval | In November, the company received FDA 510(k) clearance for use of its CUSA Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries. |
| 2025 | New Products/Services | In January, the company launched its global medical education platform, Integra Institute. |
| 2024 | Asset Purchase | In October, the company completed the acquisition of the product rights for the Durepair Regeneration Matrix (Durepair) from Medtronic Plc. |
Competitor Comparison
| Key Parameters | Integra LifeSciences Holdings Corp | Stryker Corp | Becton Dickinson and Co | Smith & Nephew Plc | Steris Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United Kingdom | Ireland |
| City | Princeton | Portage | Franklin Lakes | Watford | Dublin |
| State/Province | New Jersey | Michigan | New Jersey | England | Dublin |
| No. of Employees | 4,427 | 56,000 | 72,000 | 16,988 | 17,937 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Stuart M. Essig, Ph.D. | Chairman; Chief Executive Officer; President | Executive Board | 2012 | 64 |
| Lea Daniels Knight | Chief Financial Officer; Executive Vice President | Senior Management | 2023 | 54 |
| Dimitri Kvares | Vice President; Chief Information Officer | Senior Management | 2026 | - |
| Teshtar Elavia | Chief Technology Officer; Corporate Vice President | Senior Management | 2026 | - |
| Michael Hutchinson | Executive Vice President; Chief Legal Officer; Secretary | Senior Management | 2026 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer